Ophthalmology off the Grid
Ophthalmology off the Grid

09.16.25

A New Era of Presbyopia Drop Therapy

Blake Williamson, MD, MPH, invites Steven Dell, MD, to discuss the recent release of a new presbyopia drop—VIZZ (aceclidine ophthalmic solution, 1.44%; Lenz Therapeutics). Dr. Dell outlines why this drop represents a game-changing option for presbyopia therapy. The once-daily drop lasts for 10 hours and results in a sub-2-mm pupil size to achieve significant gains in near vision. They also review the innovation cycle of this product and how patients have responded to the treatment so far.

View full description +

MORE EPISODES

09.16.25

A New Era of Presbyopia Drop Therapy

Steven J. Dell, MD; and Blake K. Williamson, MD, MPH

08.25.25

Ushering in the Future of Cataract and Refractive Surgery

Robert J. Weinstock, MD; Gary Wörtz, MD; and Blake K. Williamson, MD, MPH

07.22.25

Potential Implications and Benefits of Direct SLT Technology

J. Morgan Micheletti, MD; Blake K. Williamson, MD, MPH; and Gary Wörtz, MD

06.06.25

Breaking Down the enVista Voluntary Recall

Cathleen McCabe, MD; Brent Saunders; Gary Wörtz, MD; and Blake K. Williamson, MD, MPH

05.20.25

The Highs and Lows of Turning an Idea Into a Business

John P. Berdahl, MD; Blake Williamson, MD, MPH; and Gary Wörtz, MD

04.22.25

Innovative Technologies to Revolutionize Practice

I. Paul Singh, MD; Gary Wörtz, MD; and Blake Williamson, MD, MPH

03.26.25

Managing the Learning Curve as an Early Adopter

William Wiley, MD; Blake Williamson, MD, MPH; and Gary Wörtz, MD

02.20.25

The Current State of Multifocal and Trifocal IOL Technologies

Blake Williamson, MD, MPH; Gary Wörtz, MD; and William Plauché, MD

Show More